Ino Aki, Sakanaka Katsuyuki, Inoo Hiroyuki, Ishida Yuichi, Kanda Junya, Mizowaki Takashi
Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507 Japan.
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507 Japan.
Int Cancer Conf J. 2021 Mar 20;10(3):201-206. doi: 10.1007/s13691-021-00479-x. eCollection 2021 Jul.
The reports for secondary esophageal cancer treated by radiotherapy or chemoradiotherapy is few, however they potentially yield a cure for esophageal cancer. We report a case of definitive radiotherapy for a patient with secondary locally advanced unresectable esophageal cancer after hematopoietic stem cell transplantation for acute myeloid leukemia. Definitive radiotherapy for the current patient was completed with acceptable toxicity despite the poor general condition with long-term chronic graft-versus-host disease. Radiotherapy may be the definitive treatment for this population unfit for concurrent chemotherapy or surgery.
关于放疗或放化疗治疗继发性食管癌的报道较少，然而它们有可能治愈食管癌。我们报告一例急性髓系白血病造血干细胞移植后发生继发性局部晚期不可切除食管癌患者的根治性放疗病例。尽管该患者因长期慢性移植物抗宿主病导致全身状况较差，但仍以可接受的毒性完成了根治性放疗。对于不适合同步化疗或手术的这类患者，放疗可能是根治性治疗方法。
